Minerva Neurosciences, Inc (NERV) Stock Price

NERVStock

$5.00+97.54%52W

Market Cap$238.74M

P/E129.98x

PEG Ratio—

Div yield—

Beta-0.08

NERV Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-36.67%

Price vs S&P 500 (4W)9.33%

VGM Score58.36

P/E Ratio (Annual)129.98x

Book Value / Share (Quarterly)$1.51

P/TBV (Annual)4.33x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-0.34

Price vs S&P 500 (YTD)7.69%

EPS (TTM)$-29.10

10-Day Avg Trading Volume0.35M

EPS Excl Extra (TTM)$-29.10

EPS (Annual)$0.19

ROI (Annual)-623.87%

Net Profit Margin (5Y Avg)-491.62%

Cash / Share (Quarterly)$1.78

P/E Normalized (Annual)129.98x

ROA (Last FY)3.88%

EBITD / Share (TTM)$-1.59

ROE (5Y Avg)-191.87%

Cash Flow / Share (Annual)$-0.31

P/B Ratio23.40x

P/B Ratio (Quarterly)4.28x

Net Income / Employee (Annual)$205,700

Net Interest Coverage (TTM)-2584.50x

ROA (TTM)-662.77%

EV / EBITDA (TTM)32.35x

EPS Incl Extra (Annual)$0.19

Current Ratio (Annual)36.28x

Quick Ratio (Quarterly)17.44x

3-Month Avg Trading Volume0.22M

52-Week Price Return97.54%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$1.49

P/S Ratio (Annual)4.55x

Asset Turnover (Annual)0.71x

52-Week High$12.46

Operating Margin (5Y Avg)-476.85%

EPS Excl Extra (Annual)$0.19

Tangible BV CAGR (5Y)-35.67%

26-Week Price Return-25.43%

Quick Ratio (Annual)35.98x

13-Week Price Return-9.25%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)17.65x

Enterprise Value$214.51M

Book Value / Share Growth (5Y)-42.53%

Revenue / Employee (Annual)$0

Pretax Margin (Annual)4.71%

Cash / Share (Annual)$1.90

3-Month Return Std Dev87.96%

Net Income / Employee (TTM)$-59,296,400

ROE (Last FY)-623.87%

Net Interest Coverage (Annual)-432.67x

EPS Basic Excl Extra (Annual)$0.19

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-29.10

ROI (TTM)-169.62%

Pretax Margin (5Y Avg)-501.48%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$1.49

Price vs S&P 500 (52W)79.23%

Year-to-Date Return19.65%

5-Day Price Return5.95%

EPS Normalized (Annual)$0.19

ROA (5Y Avg)-33.70%

Net Profit Margin (Annual)4.71%

Month-to-Date Return20.85%

Cash Flow / Share (TTM)$-3.53

EBITD / Share (Annual)$-2.91

Operating Margin (Annual)4.49%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-191.73%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-29.10

P/TBV (Quarterly)4.33x

P/B Ratio (Annual)4.28x

Book Value / Share (Annual)$1.51

Price vs S&P 500 (13W)-12.04%

Beta-0.08x

P/FCF (Annual)61.57x

Revenue / Share (TTM)$0.00

ROE (TTM)-169.62%

52-Week Low$1.93

mGradeC

vgmGradeC

NERV Earnings Surprise History

Q2 25-0.43est. -0.90

Q3 25-0.36est. —

Q4 25-0.64est. -0.11

Q1 26-0.17est. -0.13

Q2 26-0.17est. -0.01

NERV Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.89

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
NERVMinerva Neurosciences, Inc	—	—	C	$5.00
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Minerva Neurosciences, Inc

Minerva Neurosciences is a clinical-stage biopharmaceutical company developing treatments for central nervous system disorders. Its pipeline includes Roluperidone for schizophrenia negative symptoms, Seltorexant for insomnia and depression, and MIN-301 for Parkinson's disease.